7th Coronary Artery Anomalies Symposium

Thursday, December 3, 2026, 8:00 AM - Friday, December 4, 2026, 6:00 PM, Jan and Dan Duncan Neurological Research Institute (NRI) Conference Center, Houston, TX


AMA PRA Category 1 Credits™ (11.00 hours), Non-Physician Attendance (11.00 hours)

Sudden death in the young athlete is a rare but devastating event that assumes high public coverage. The diagnosis can be challenging, depending on the expertise of the team assessing the athlete or patient. In addition, the clinical manifestations might be fruste to silent and there is paucity of data to date how to best identify anomalous aortic origin of a coronary artery, the second leading cause of sudden death in the young athlete. The conference aim is to increase knowledge regarding coronary anomalies from infancy to adulthood, to include evaluation modalities (PET, stress CMR, advances in SPECT imaging) for risk stratification, role of genetic testing in aborted sudden cardiac death, surgical approach to coronary anomalies, coronary complications, medical therapy considerations (role of betablockers and statins), exercise and sports participation and emerging technology (artificial intelligence).

1. Describe standardized nomenclature used in the ICAC framework
2. Compare imaging modalities used for anatomical and physiological assessment in the evaluation of coronary anomalies
3. Identify management strategies for R-AAOCA and L-AAOCA variants
4. Identify high-risk anatomical features (interarterial, intraseptal, etc.)
5. Describe contemporary surgical interventions for coronary anomalies (ostioplasty, unroofing, reimplantation, transconal techniques)
6. Identify coronary anomaly short- and long-term complications and management strategies (e.g., MI, arrhythmias, heart failure)
7. Describe long-term ischemic risks associated with ALCAPA/ARCAPA and medical management strategies
8. Compare evaluation strategies between isolated AAOCA and CHD-associated intramural coronaries
9. Discuss emerging concepts in computational simulation modeling
10. Identify recommended safe return-to-play strategies post sudden cardiac arrest based on current evidence

Click here for Family Conference Registration

Texas Children’s Hospital is accredited by the Texas Medical Association to provide continuing medical education for physicians. Texas Children’s Hospital designates this Live Activity activity for a maximum of 11.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Texas Children’s Hospital is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This nursing continuing professional development (NCPD) activity awards up to {NursingHours} contact hours.

Cancellation Policy

Cancellations received in writing no less than 20 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to [email protected].

Texas Children's Hospital reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 
Texas Children's Hospital is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

You are not logged in.

Please click the button below to login or create a new account before continuing.

Texas Children's Hospital adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Texas Children's Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including Faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible company (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.

Welcome to the 7th Symposium on Coronary Artery Anomalies abstract submission portal! We invite trainees, students, clinicians, and investigators with projects relevant to coronary artery anomalies to submit their work for consideration. This is an excellent opportunity to showcase your research, receive feedback from experts in the field, and connect with colleagues dedicated to advancing knowledge and care in the coronary artery anomalies community. Accepted abstracts will be presented as posters and displayed throughout the conference. Authors will have the opportunity to discuss their work with attendees during breaks in the scientific sessions and engage in meaningful scientific exchange.
o Abstract Awards: The top three abstracts will be recognized and awarded at the conclusion of the symposium.
o Fee for abstract submission: No fee!

2500 character limitation (including all spaces and punctuation) including the abstract body, methods, results and conclusion of the research.
Formatting: Body of the abstract should be standard Arial or Times New Roman (11 or 12 pt font), submitted as a Word document (.doc/.docx) or PDF file (.pdf) via online Cloud CME portal
Language: English
Structure:

• Title: Concise and specific; avoid using abbreviations or teasing final results
• Background/ Introduction: Establish the rationale, the knowledge gap and your core objective or hypothesis.
• Methods: Briefly summarize the study design, main materials, or cohort description.
• Results: Highlight key findings and primary data points that directly address your aims.
• Conclusion: State the primary takeaway and broader clinical or scientific implications.
• Tables, figures and graphs may be included. If you have tables or images, please email a one-page Words or PowerPoint with corresponding labels (Table1 or Image 1, Table 2 or Image 2, etc) to [email protected]
  

• Limit of 3 images.
• All graphics (figures) and text-based graphics (tables) should be provided as 72- 300 dpi, pre-sized .BMP, .GIF, .JPG or .PNG images only, with a maximum width of 440 pixels (no limit on length).
• Black-and-white digital images should be in grayscale mode. Color images should be saved in RGB color mode.
• All graphics will require a brief description of the image.

• Deadline: Deadline for submission is midnight CST on 10/15/2026
• Notification of acceptance: 11/04/2026 by email.

Submit your Abstract

View Submitted Abstracts